Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
The Association of Racing Commissioners International's board of directors has unanimously approved a drug reclassification of stanozolol, boldenone, nandrolone, and testosterone, moving the anabolic steroids to Class 3 from Class 4.
A 45-day public comment period started March 2 on a series of rule amendments and additions under consideration by the California Horse Racing Board revising classification of drug substances and penalties for medication violations.
The California Horse Racing Board Medication Committee will consider major changes to the state's medication rules and penalties during a meeting Jan. 9 at Santa Anita Park.
Most Popular Stories
- Winx Soars to Fifteenth Straight Win
- Weekend Stakes Rundown: Fair Grounds in the Spotlight
- Veteran Kentucky-Based Hot Walker Roche Dies at 91
- Irish War Cry Ticks All the Boxes in Five-Furlong Work
- Broken Pelvis Cause of Charismatic's Death
- Horse of the Year Charismatic Dies
- Baffert Talks 2017 Triple Crown
- Louis Quatorze Dies of Heart Attack
- Elliott Honored with George Woolf Memorial Jockey Award
- Oscar Performance Targeting Keeneland for Season Debut